XTL Biopharmaceuticals Ltd. (XTLB)
Market Closed
15 Oct, 03:25 PM
TASE TASE Primary 1. 50
ILA -0.1
-6.25%
35.96M Market Cap
- P/E Ratio
- Div Yield
1.54M Volume
- Eps
1.6 ILA
Previous Close Want to track XTLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XTL Biopharmaceuticals Ltd. (XTLB) Statistics
Valuation metrics
Market Cap 35.96M
Enterprise value 5.14M
Trailing P/E (ttm) -0.65
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 11.38
Price/Book (mrq) -18.45
Enterprise Value/Revenue 11.76
Enterprise Value/EBITDA -4.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.53M
Average volume (90 days) 1.08M
Price summary
52-Week low 1.5
52-Week high 5.2
Beta -
50-Day moving average 1.86
200-Day moving average 1.96
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.2:1
Last split Date 22 Jun 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.64%
Operating margin -14.71%
Operational effectiveness
Return on assets -41.98%
Return on equity -2.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -1.06
Current ratio (mrq) 0.4%
Book value per share (mrq) -0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
